Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
12
2021
FDA Issues New Draft Guidance on Imported Food Keller and Heckman LLP
Jul
12
2021
Biden Executive Order Addresses Healthcare Industry Competition, Targets Pharmaceuticals, Pricing, and Hospital Mergers Nelson Mullins
Jul
9
2021
New Yorkers Support Icon for Sugary Menu Items Keller and Heckman LLP
Jul
9
2021
South Korean Study Indicates that Food Contact Plastic Materials are Properly Controlled by Existing Regulations Keller and Heckman LLP
Jul
9
2021
Bipartisan Legislation Proposed to Authorize CBD Dietary Supplements and Food Additives Beveridge & Diamond PC
Jul
9
2021
NanoHarmony Survey Asks Stakeholders about Their Experiences with OECD Test Guidelines and Guidance Documents Bergeson & Campbell, P.C.
Jul
9
2021
Commission Launches EU Code of Conduct on Responsible Food Business and Marketing Practices Keller and Heckman LLP
Jul
9
2021
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications - July 8, 2021 Keller and Heckman LLP
Jul
9
2021
Latest Open Payments Data Released Under Heightened Government Scrutiny Foley & Lardner LLP
Jul
8
2021
340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case K&L Gates
Jul
8
2021
The Re-Emergence of Ecstasy – But Not at the Club Womble Bond Dickinson (US) LLP
Jul
8
2021
Oregon Temporarily Allows Vaccine Incentives and Hiring Bonuses Jackson Lewis P.C.
Jul
8
2021
Cannabis Directors and Officers Liability: Cause for Optimism? Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
8
2021
Nature’s Path Sued for Overstating Protein Keller and Heckman LLP
Jul
8
2021
China’s National Intellectual Property Administration Releases Patent Linkage Administrative Adjudication Measures Schwegman, Lundberg & Woessner, P.A.
Jul
8
2021
Transparency in Prescription Drug Pricing: Recent State and Federal Developments to Watch Greenberg Traurig, LLP
Jul
7
2021
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements K&L Gates
Jul
7
2021
Mexico’s Supreme Court Finds General Health Law Articles Prohibiting Recreational Use of Marijuana Unconstitutional Greenberg Traurig, LLP
Jul
7
2021
House Asks FDA to Clarify Plant-Based Food Labels Keller and Heckman LLP
Jul
6
2021
The Supreme Court of Justice Authorized the Recreational Use of Cannabis OLIVARES
Jul
6
2021
China Releases Patent Linkage Implementation Measures Schwegman, Lundberg & Woessner, P.A.
Jul
6
2021
EC Requests Scientific Opinion on Fullerenes and Hydroxylated Fullerenes Bergeson & Campbell, P.C.
Jul
6
2021
7th Circuit Affirms Summary Judgment in Favor of Defendant Champion Petfoods Keller and Heckman LLP
Jul
2
2021
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation Sheppard, Mullin, Richter & Hampton LLP
Jul
2
2021
FDA Releases Cyclospora Action Plan Keller and Heckman LLP
Jul
1
2021
More than Innovation and Competition: The Latest Proposed Monitoring and Enforcement Mechanisms Targeting Foreign Influence in U.S. Research K&L Gates
Jul
1
2021
Failure To State Cost Of Confirmatory Re-Test Violates Iowa Drug Testing Law Jackson Lewis P.C.
Jul
1
2021
EC Committee Needs More Data to Assess Safety of the Nanomaterials Gold, Colloidal Gold, and Surface Modified Gold Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins